z-logo
Premium
TH‐C‐201C‐04: Breathing Motion and Deformation of Pancreatic Cancer Patients and Its Effect on Planning Dose
Author(s) -
Nguyen TN.,
Moseley J.L.,
Dawson L.A.,
Brock K.K.
Publication year - 2010
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.3469509
Subject(s) - medicine , nuclear medicine , pancreatic cancer , pancreas , breathing , duodenum , dosimetry , radiation therapy , radiation treatment planning , cancer , radiology , anatomy , surgery
Purpose : Generate a deformable model of the pancreas and surrounding anatomy and evaluate the dosimetric impact of respiration motion on the pancreas and the surrounding organs‐at‐risk (OARs) during radiation therapy for pancreatic cancer. Methods and Materials : A multi‐organ biomechanical model‐based deformable image registration platform (MORFEUS) characterize exhale to inhale breathing motion from the 4DCT treatment planning images of seven pancreatic cancer patients. The deformed pancreas and OARs were compared to their respective volumes contoured on the inhale images using a volume overlap criteria (DICE). The dose delivered to the OARs during free breathing was calculated using MORFEUS and compared to the static planning dose. Results : The DICE using MORFEUS for the pancreas duodenum left and right kidneys was (mean±SD) 0.79±0.06 0.71±0.08 0.89±0.05 and 0.88±0.06 respectively. The effect of breathing on the max and mean dose was small however differences were seen in the dose to a percentage of the volume. For the duodenum 4 patients had an average dose difference of 1.9±0.9 Gy for 60–90% volume (max 4 Gy). Similarly for the stomach 6 patients had an average dose difference of 1.8±1.1 Gy for 20–50% of the volume (3 patients had > 3 Gy). One patient had 1.8 Gy difference to 40% of the bowel volume. Conclusion : A deformable model of the pancreatic cancer anatomy was developed and shown to provide good volume overlap. Due to the overlap of the CTV with the OARs the dosimetric effect of breathing on the overall max dose was small however changes of more than 1 Gy were observed in the duodenum stomach and bowel to a percent of the volume which may have clinical significance especially in these patients treated with combined radiosensitizers. Research sponsored by NIH 5RO1CA124714‐02 Elekta Oncology Systems and K. Brock is supported by a Cancer Care Ontario Research Chair.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom